GlassScriptPhysician profile
Bruce Binkley Hill
NPI 1699715664
$23,333.16
in general payments reported to CMS, 2019-2025
15 companies · $647 in 2025
The $647 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,196 · 2020: $959 · 2021: $184 · 2022: $791 · 2023: $12K · 2024: $1,061 · 2025: $647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Food and Beverage: $1,005 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Gift: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,000.00 |
| Food and Beverage | $1,005.47 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Gift | $197.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $20,915.55 | 2019-2025 | Da Vinci Surgical System |
| Zimmer Biomet Holdings, INC. | $837.09 | 2020-2021 | |
| Stryker Corporation | $406.87 | 2022 | |
| Davol INC. | $399.31 | 2019-2021 | |
| Tela Bio, INC. | $268.63 | 2020-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $134.73 | 2021-2024 | Surgicel Nu-Knit, Stratafix, Harmonic |
| Covidien LP | $134.73 | 2019 | |
| Teleflex LLC | $63.98 | 2019-2022 | |
| Aroa Biosurgery Incorporated | $43.60 | 2022 | |
| Acell, INC. | $27.63 | 2020 | |
| Shire North American Group INC | $26.96 | 2019 | |
| Portola Pharmaceuticals, LLC | $24.94 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $19.06 | 2019 | |
| Heron Therapeutics, INC. | $18.89 | 2021 | |
| Baudax Bio INC. | $11.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.